Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1979 2
1980 3
1981 5
1982 5
1983 4
1984 9
1985 5
1986 2
1987 1
1988 2
1989 4
1990 1
1991 1
1992 5
1993 2
1994 3
1995 4
1996 3
1997 5
1998 4
1999 6
2000 3
2001 7
2002 6
2003 9
2004 5
2005 11
2006 9
2007 3
2008 5
2009 6
2010 14
2011 14
2012 8
2013 6
2014 9
2015 7
2016 7
2017 4
2018 10
2019 3
2020 10
2021 15
2022 11
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

255 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.
Cortes J, Rugo HS, Cescon DW, Im SA, Yusof MM, Gallardo C, Lipatov O, Barrios CH, Perez-Garcia J, Iwata H, Masuda N, Torregroza Otero M, Gokmen E, Loi S, Guo Z, Zhou X, Karantza V, Pan W, Schmid P; KEYNOTE-355 Investigators. Cortes J, et al. N Engl J Med. 2022 Jul 21;387(3):217-226. doi: 10.1056/NEJMoa2202809. N Engl J Med. 2022. PMID: 35857659 Clinical Trial.
SERDs for primary breast cancer.
Toi M, Aruga T. Toi M, et al. Among authors: aruga t. Lancet Oncol. 2023 Sep;24(9):947-949. doi: 10.1016/S1470-2045(23)00291-7. Lancet Oncol. 2023. PMID: 37657466 No abstract available.
Early breast cancer.
Suzuki T, Toi M, Saji S, Horiguchi K, Aruga T, Suzuki E, Horiguchi S, Funata N, Karasawa K, Kamata N. Suzuki T, et al. Among authors: aruga t. Int J Clin Oncol. 2006 Apr;11(2):108-19. doi: 10.1007/s10147-006-0564-7. Int J Clin Oncol. 2006. PMID: 16622745 Review.
Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM).
Niikura N, Yamanaka T, Nomura H, Shiraishi K, Kusama H, Yamamoto M, Matsuura K, Inoue K, Takahara S, Kita S, Yamaguchi M, Aruga T, Shibata N, Shimomura A, Ozaki Y, Sakai S, Kiga Y, Izutani T, Shiosakai K, Tsurutani J. Niikura N, et al. Among authors: aruga t. NPJ Breast Cancer. 2023 Oct 11;9(1):82. doi: 10.1038/s41523-023-00584-5. NPJ Breast Cancer. 2023. PMID: 37821514 Free PMC article.
Evaluation of a novel medical device for pegfilgrastim administration.
Aruga T, Doihara H, Yanagita Y, Ishida T, Yamashita T, Uehara K, Taira T, Tsurutani J, Takeshita T, Tsuyuki S, Kaneko K, Ohtake T, Yamaguchi Y, Hara Y, Saji S. Aruga T, et al. Cancer Sci. 2022 May;113(5):1763-1770. doi: 10.1111/cas.15335. Epub 2022 Mar 29. Cancer Sci. 2022. PMID: 35293085 Free PMC article.
Patients Offer Radiofrequency Ablation Therapy for Early Breast Cancer as Local Therapy (PO-RAFAELO) Study under the Patient-proposed Health Services.
Takayama S, Kinoshita T, Shiino S, Jimbo K, Watanabe KI, Fujisawa T, Yamamoto N, Onishi T, Shien T, Ito M, Takahashi M, Futamura M, Aruga T, Kaneko K, Suto A. Takayama S, et al. Among authors: aruga t. JMA J. 2023 Oct 16;6(4):505-512. doi: 10.31662/jmaj.2023-0047. Epub 2023 Oct 2. JMA J. 2023. PMID: 37941717 Free PMC article. Clinical Trial.
A flat-lying dimer as a key intermediate in NO reduction on Cu(100).
Kuroishi K , Al Fauzan MR , Pham TN , Wang Y , Hamamoto Y , Inagaki K , Shiotari A , Okuyama H , Hatta S , Aruga T , Hamada I , Morikawa Y . Kuroishi K , et al. Among authors: aruga t. Phys Chem Chem Phys. 2021 Aug 12;23(31):16880-16887. doi: 10.1039/d1cp02746h. Phys Chem Chem Phys. 2021. PMID: 34328163 Free article.
255 results